Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Therapeutic Drug Monitoring (TDM) is indicated for which of the following drugs?

Metformin. **Explanation** **Therapeutic Drug Monitoring (TDM)** is a clinical practice where the plasma concentration of a drug is measured to maintain it within a specific "therapeutic window." It is typically indicated for drugs with a narrow therapeutic index, high inter-individual pharmacokinetic variability, or a direct correlation between plasma levels and toxicity [1]. **Why Metformin is the Correct Answer (in the context of NOT requiring TDM):** Metformin is an oral hypoglycemic agent used for Type 2 Diabetes. It has a **wide therapeutic index**, and its efficacy is monitored clinically by measuring blood glucose levels and HbA1c, rather than plasma drug concentrations [4]. Therefore, TDM is **not** indicated for Metformin. **Analysis of Incorrect Options (Drugs requiring TDM):** * **Theophylline:** A bronchodilator with a narrow therapeutic window [1]. Toxicity (arrhythmias, seizures) can occur at levels only slightly higher than therapeutic doses. * **Lithium:** Used in Bipolar Disorder; it has an extremely narrow therapeutic range (0.6–1.2 mEq/L). Levels >1.5 mEq/L are toxic, necessitating frequent monitoring. * **Phenytoin:** An antiepileptic that exhibits **zero-order (saturation) kinetics** at therapeutic doses [2]. Small dose increases can lead to disproportionately large increases in plasma levels and toxicity (ataxia, nystagmus) [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Indications for TDM:** Narrow therapeutic index (Digoxin, Aminoglycosides), non-linear kinetics (Phenytoin), or drugs where toxicity is difficult to distinguish from the disease (Theophylline) [1], [2]. * **TDM is NOT required for:** Drugs with easily measurable physiological markers (e.g., BP for Antihypertensives, INR for Warfarin, Blood sugar for Metformin/Insulin) [4]. * **Sampling Time:** TDM is usually performed at **steady state** (after 4–5 half-lives) using "trough" concentrations (just before the next dose) [1].

Q: All the following drugs are given by sublingual route EXCEPT:

Isosorbide-5-mononitrate. **Explanation:** The correct answer is **Isosorbide-5-mononitrate (ISMN)**. The sublingual route is chosen for drugs that require a rapid onset of action or those that undergo extensive **first-pass metabolism** in the liver. By bypassing the portal circulation, these drugs enter the systemic circulation directly via the sublingual venous plexus. * **Isosorbide-5-mononitrate (Option D):** This is the active metabolite of Isosorbide dinitrate. It has **100% oral bioavailability** and does not undergo significant first-pass metabolism. Therefore, it is administered orally (tablets) for the chronic prophylaxis of angina, not for acute relief. * **Glyceryl trinitrate (GTN) and Isosorbide dinitrate (ISDN) (Options A & C):** Both are organic nitrates used for the acute termination of an angina attack. They undergo massive first-pass metabolism (low oral bioavailability), making the sublingual route essential for rapid absorption and immediate effect. * **Buprenorphine (Option B):** This is a potent opioid used for pain and opioid de-addiction. It undergoes significant first-pass metabolism if swallowed; hence, it is commonly formulated as a sublingual tablet to ensure therapeutic systemic levels. **High-Yield Clinical Pearls for NEET-PG:** 1. **Nitrate of choice for acute angina:** Sublingual Glyceryl trinitrate (Nitroglycerin). 2. **Longest acting nitrate:** Isosorbide-5-mononitrate (due to its high bioavailability and long half-life). 3. **Other drugs given sublingually:** Nifedipine (historically for hypertensive emergencies, though now discouraged), Desmopressin, and certain triptans (Zolmitriptan). 4. **Advantage:** Avoids gastric acid degradation and hepatic first-pass effect.

Q: Proton Pump Inhibitors cause prolonged suppression of acid secretion despite having a short half-life because of which of the following reasons?

They inhibit the proton pump irreversibly.. ### Explanation **Correct Option: D. They inhibit the proton pump irreversibly.** The duration of action of a drug is usually determined by its plasma half-life ($t_{1/2}$). However, Proton Pump Inhibitors (PPIs) like Omeprazole are a classic exception. Although they have a short plasma half-life (approx. 1–2 hours), their effect lasts for 24–48 hours. This is because PPIs form a **covalent disulfide bond** with the $H^+/K^+$-ATPase enzyme (the proton pump) on the luminal surface of gastric parietal cells. This **irreversible inhibition** means that acid secretion can only resume once the cell synthesizes **new pump molecules**, a process that takes significant time. **Analysis of Incorrect Options:** * **Option A:** While PPIs are pro-drugs activated in an acidic environment, this activation is rapid, not gradual, and does not explain the prolonged duration of action. * **Option B:** PPIs do concentrate in the acidic canaliculi (ion trapping), but this is a transient phase of their pharmacokinetics. The long-term effect is due to the chemical bond formed, not just their physical presence. * **Option C:** Enteric coating is used to protect the acid-labile drug from gastric acid so it can be absorbed in the alkaline duodenum; it is not a "sustained-release" mechanism for prolonged action. **High-Yield Clinical Pearls for NEET-PG:** * **Hit-and-Run Drugs:** PPIs are the prototype of "hit-and-run" drugs—drugs whose effect persists long after they have been cleared from the plasma. * **Administration:** PPIs should be taken **30–60 minutes before a meal** (usually breakfast) because the number of $H^+/K^+$-ATPase pumps at the canalicular surface is maximal after a fast. * **Drug of Choice (DOC):** PPIs are the DOC for Peptic Ulcer Disease (PUD), GERD, and Zollinger-Ellison Syndrome.

Q: Which of the following drugs has the least oral bioavailability?

d-tubocurarine. **Explanation:** The correct answer is **d-tubocurarine (Option A)**. **1. Why d-tubocurarine is correct:** Bioavailability is the fraction of an administered drug that reaches the systemic circulation in an unchanged form. **d-tubocurarine** is a quaternary ammonium compound. Due to its strong positive charge, it is highly ionized at all physiological pH levels. Highly ionized drugs are **lipid-insoluble**, meaning they cannot cross the lipid bilayer of the gastrointestinal tract. Consequently, its oral bioavailability is nearly **zero**, necessitating intravenous administration for its effect as a neuromuscular blocker. **2. Why the other options are incorrect:** * **Morphine (B):** While morphine undergoes significant **first-pass metabolism** in the liver (reducing its bioavailability to ~25-30%), it is still absorbed from the gut and can be administered orally for chronic pain management. * **Ampicillin (C):** This is an acid-stable penicillin. Although its absorption is incomplete and can be decreased by food, it has a bioavailability of approximately 30-50%, making it effective via the oral route. * **Phenytoin (D):** This antiepileptic drug has high oral bioavailability (approx. 70-90%), though it exhibits slow and variable absorption. **3. Clinical Pearls for NEET-PG:** * **Quaternary Ammonium Compounds:** Drugs like d-tubocurarine, neostigmine, and ipratropium are permanently charged; they do not cross the GI tract or the Blood-Brain Barrier (BBB). * **First-Pass Effect:** High first-pass metabolism (e.g., Nitroglycerin, Lidocaine, Morphine) is a common reason for low bioavailability, but **poor lipid solubility** (e.g., Aminoglycosides, d-tubocurarine) results in the *least* oral absorption. * **Bioavailability (F):** For IV administration, F = 100% (or 1). For all other routes, F < 1.

Q: Which of the following properties of a drug will enable it to be used in low concentrations?

High stability. **Explanation:** The correct answer is **High stability (Option D)**. In pharmacokinetics, the concentration of a drug required to maintain a therapeutic effect is heavily influenced by its **half-life and metabolic stability**. A drug with high stability is resistant to rapid degradation by hepatic enzymes (like Cytochrome P450) or renal excretion. Because it remains in the systemic circulation for a longer duration, it can achieve and maintain the desired therapeutic effect even when administered in **low concentrations** or infrequent doses. **Analysis of Incorrect Options:** * **High Affinity (A):** Affinity refers to the strength of binding between a drug and its receptor. While high affinity means a drug can bind even at low concentrations, it does not dictate the overall concentration required in the body if the drug is rapidly metabolized. * **High Specificity (B):** Specificity refers to the drug’s ability to bind to a particular receptor type. High specificity reduces side effects (off-target binding) but does not inherently allow for lower dosing concentrations; it relates more to the *quality* of the effect rather than the *quantity* of the drug needed. * **Low Specificity (C):** This usually leads to more side effects and often requires higher doses to ensure enough drug reaches the intended target site. **NEET-PG High-Yield Pearls:** * **Potency vs. Efficacy:** Potency (related to affinity) determines the *dose* required for an effect, but **Stability** determines the *maintenance* of that concentration over time. * **Steady State:** It takes approximately 4–5 half-lives to reach a steady-state concentration. Drugs with high stability (long half-lives) reach this state slowly but sustain it longer. * **Clinical Example:** Drugs like **Amlodipine** or **Digitoxin** have high stability/long half-lives, allowing for once-daily dosing at relatively low concentrations compared to rapidly metabolized alternatives.

Q: Which of the following drugs used in the management of bronchial asthma follows zero-order kinetics?

Theophylline. **Explanation:** **Theophylline** is the correct answer because it exhibits **capacity-limited elimination**, also known as **Zero-order kinetics**, at higher therapeutic or toxic concentrations. While most drugs follow first-order kinetics (where a constant fraction of the drug is eliminated per unit time), zero-order kinetics implies that a **constant amount** of the drug is eliminated regardless of its plasma concentration. This occurs because the metabolic enzymes in the liver become saturated. Consequently, even a small dose increase can lead to a disproportionate rise in plasma levels, increasing the risk of toxicity (narrow therapeutic index). **Analysis of Incorrect Options:** * **Salbutamol (A):** A short-acting beta-2 agonist (SABA) that follows first-order kinetics. It is primarily used as a rescue inhaler. * **Phenytoin (B):** While Phenytoin **does** follow zero-order kinetics (saturation kinetics), the question specifically asks for a drug used in the **management of bronchial asthma**. Phenytoin is an anti-epileptic. * **Tiotropium (C):** A long-acting muscarinic antagonist (LAMA) used in COPD and asthma that follows first-order kinetics. **NEET-PG High-Yield Pearls:** * **Mnemonic for Zero-Order Kinetics:** "**WATT P**a**S**" – **W**arfarin (at high doses), **A**lcohol (Ethanol), **T**heophylline, **T**olbutamide, **P**henytoin, and **S**alicylates (Aspirin). * Theophylline has a narrow therapeutic range (**10–20 µg/mL**). Toxicity manifests as severe vomiting, cardiac arrhythmias, and seizures. * In zero-order kinetics, the **half-life (t½) is not constant**; it increases as the plasma concentration increases.

Q: Which drug is excreted unchanged in the urine?

Furosemide. **Explanation:** The correct answer is **Furosemide**. **1. Why Furosemide is correct:** Furosemide is a potent loop diuretic that acts on the thick ascending limb of the Henle’s loop. A significant portion of furosemide (approximately 60–90%) is excreted **unchanged in the urine** via glomerular filtration and active tubular secretion through the organic anion transport system. This is clinically significant because the drug must reach the tubular lumen to exert its diuretic effect. **2. Why the other options are incorrect:** * **Verapamil:** This calcium channel blocker undergoes extensive **first-pass metabolism** in the liver. It is primarily excreted as metabolites in the urine, with less than 5% excreted unchanged. * **Propranolol:** A highly lipid-soluble beta-blocker, propranolol is almost entirely metabolized by the **liver** (oxidation and glucuronidation). It has a high first-pass effect, and negligible amounts are excreted unchanged. * **Thiopentone:** This is an ultra-short-acting barbiturate. Its action is terminated by **redistribution** from the brain to muscle and fat, but it is ultimately metabolized almost completely by the liver before excretion. **3. NEET-PG High-Yield Pearls:** * **Lipid Solubility vs. Excretion:** Highly lipid-soluble drugs (like Propranolol and Thiopentone) are easily reabsorbed in the renal tubules and must be metabolized into polar (water-soluble) compounds by the liver to be excreted. * **Water-Soluble Drugs:** Drugs excreted unchanged in the urine are typically polar/water-soluble. Other examples include **Atenolol, Digoxin, Ethambutol, and Aminoglycosides**. * **Dose Adjustment:** Drugs excreted unchanged in the urine require strict dose reduction in patients with **Renal Failure** to prevent toxicity.

Question 1

Therapeutic Drug Monitoring (TDM) is indicated for which of the following drugs?

Accepted Answer

Metformin

Answer

Theophylline

Answer

Lithium

Answer

Phenytoin

Question 2

All the following drugs are given by sublingual route EXCEPT:

Accepted Answer

Isosorbide-5-mononitrate

Answer

Isosorbide dinitrate

Answer

Buprenorphine

Answer

Glyceryl trinitrate

Question 3

Proton Pump Inhibitors cause prolonged suppression of acid secretion despite having a short half-life because of which of the following reasons?

Accepted Answer

They inhibit the proton pump irreversibly.

Answer

Their pro-drug form gets activated gradually.

Answer

They enter acid secretory canaliculi and stay there, blocking the secretion of acid for a long time.

Answer

Enteric coated capsules which release the drug gradually.

Question 4

Which of the following drugs has the least oral bioavailability?

Accepted Answer

d-tubocurarine

Answer

Morphine

Answer

Ampicillin

Answer

Phenytoin

Question 5

Which of the following properties of a drug will enable it to be used in low concentrations?

Accepted Answer

High stability

Answer

High affinity

Answer

High specificity

Answer

Low specificity

Question 6

Side effects of a drug arise due to the interactions of the drug with molecules other than its intended target. These effects can be minimized by maximizing the drug's?

Accepted Answer

Specificity

Answer

Affinity

Answer

Solubility

Answer

Hydrophobicity

Question 7

Which of the following drugs used in the management of bronchial asthma follows zero-order kinetics?

Accepted Answer

Theophylline

Answer

Salbutamol

Answer

Phenytoin

Answer

Tiotropium

Question 8

The pharmacokinetics of Paroxetine include its ability to be easily absorbed after oral administration in healthy volunteers even after food is ingested. Which of the following is TRUE regarding Paroxetine's pharmacokinetics?

Accepted Answer

Less than 1% of the drug is in systemic circulation owing to extensive distribution in body tissues.

Answer

The main portion of the medication resides in systemic circulation.

Answer

Little of the medication is absorbed into the tissues.

Answer

Less than 25% is eliminated by the kidneys.

Question 9

Which drug is excreted unchanged in the urine?

Accepted Answer

Furosemide

Answer

Verapamil

Answer

Propranolol

Answer

Thiopentone

Question 10

Which of the following most accurately describes the transmembrane signaling process involved in the steroid hormone action?

Accepted Answer

Diffusion across the membrane and binding to an intracellular receptor

Answer

Action on a membrane spanning tyrosine kinase

Answer

Action of a G protein, which activates or inhibits adenylyl cyclase

Answer

Opening of transmembrane ion channels

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?